As of Mar 28, 2026, Camlin Fine Sciences Ltd (Chemicals - Others) has a deep value score of 10/100 (rated Very Weak).
Deep value thesis based on recent earnings • Updated Mar 21, 2026
Temporary operational disruptions mask an emerging margin recovery in Vanillin business with US tariff relief expected to catalyze earnings inflection in Q4 FY26.
Verdict
EARLY_INNINGS
Re-rating catalysts over the next 2-4 quarters • Updated Mar 21, 2026
Expected reduction from 25% to 18% will boost Vanillin export margins by ~700 bps, potentially adding Rs. 50-70 cr to annual EBITDA
Impact: +₹50 Cr revenue
“Management guidance on tariff relief and Vanillin business recovery”
Full-quarter contribution from natural ingredients portfolio expected to lift specialty ingredients revenue by 15% with 20%+ EBITDA margins
“Vinpai acquisition strengthens natural ingredients portfolio”
Management targeting D/E below 0.5x by FY27 end from current 0.65x, potentially triggering credit rating upgrade
“Long-term debt reduced from Rs. 332.72 cr to Rs. 268.30 cr”
Risks that could prevent re-rating or deepen the value trap
Continued pricing pressure in commoditized Straights segment
Impact: -1070 bps margin impact
Management view: Management focusing on Value Added Blends to offset Straights decline
Monitor: Straights segment revenue trend
Continued operational disruptions affecting working capital cycle
Management view: Management expects improvement as Brazil fire incident effects subside
Monitor: CFO to PAT ratio
Further increase in promoter pledge or related party transactions
Management view: Not explicitly addressed in recent communications
Monitor: Promoter pledge percentage
Forward-looking targets from management for FY27
Revenue Growth Target
8%
Implied PAT Growth
250%
OPM Guidance
8.5%
Capex Plan
₹150 Cr
Key Milestones
• US tariff relief realization
• Vinpai integration completion
• D/E below 0.5x achievement
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +6% | +6% | Decelerating |
| PAT (Net Profit) | -429% | -50% | Inflection Down |
| OPM | 5.0% | -800 bps | Volatile |
The above analysis is AI-generated from publicly available financial data. This is educational research only — not investment advice. Last updated Mar 21, 2026.
Based on publicly available financial data. This is educational research, not investment advice.
Camlin Fine Sciences Ltd has a deep value score of 10/100 (rated Very Weak). This score is calculated from three components
Camlin Fine Sciences Ltd's quarterly profit (PAT) growth trajectory
Camlin Fine Sciences Ltd is underperforming the market despite improving earnings — this is the core deep value thesis
Camlin Fine Sciences Ltd's earnings momentum is Monitoring.
Camlin Fine Sciences Ltd's valuation metrics
Camlin Fine Sciences Ltd's revenue and margin trends
Camlin Fine Sciences Ltd's trailing twelve month (TTM) performance
Camlin Fine Sciences Ltd key facts
Camlin Fine Sciences Ltd shows limited deep value signals currently — score is 10/100 (Very Weak). Monitor for improvement.
Other deep value stocks in Chemicals - Others
Chemicals - Others deep value sector overview
Deep value investing studies stocks that are underperforming the market despite showing improving fundamentals. The thesis is that the market has not yet recognized the earnings recovery, creating a potential valuation gap. It requires patience — recovery can take several quarters.
The deep value score (0-100) combines three factors:
- Earnings (0-40 pts): PAT growth across last 3 quarters, acceleration, and consecutive growth - Underperformance (0-35 pts): How much the stock trails Nifty 500 over 1Y, 6M, 3M (deeper underperformance = higher score) - Quality (0-25 pts): Revenue growth, margin trends, and valuation metrics (PEG, P/B)
Higher score indicates a stronger contrarian research signal.
Camlin Fine Sciences Ltd has 3 key growth catalysts identified from recent earnings analysis
Camlin Fine Sciences Ltd has 3 key risks worth monitoring
The above FAQs are generated from publicly available earnings data. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.
